Loading the company…
Loading the company…
In the last ten years FDA made 107 decisions for Cochlear (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2017 (21). The latest was on 2026-09-28.
| Family | Decisions on record |
|---|---|
| Cochlear implants | 400 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-09-28 | PMA | P840024-S099 | Nucleus® 22 Cochlear Implant System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-09-28 | PMA | P970051-S244 | Nucleus® 24 Cochlear Implant System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-09-28 | PMA | P890027-S067 | Nucleus® 22 Cochlear Implant System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-04-30 | PMA | P970051-S242 | Nucleus® 24 Cochlear Implant System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
In 2025, Cochlear reported engagement with 975 surgeons and other clinicians in the states MedaRep covers, worth $706K in consulting, speaking, meals and travel for its device products, the most in Missouri ($99K to 27). Royalties are left out.
| 2025-12-19 | PMA | P970051-S240 | NUCLEUS 24 COCHLEAR IMPLANT SYSTEM · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Cochlear.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Missouri ($99K, 27 engaged), Colorado ($60K, 23 engaged), California ($59K, 126 engaged), Minnesota ($57K, 14 engaged), Ohio ($56K, 38 engaged).